Anthelmintic Drugs Market: Introduction
According to the report, the global anthelmintic drugs market was valued at ~US$ 2 Bn in 2019 and
is projected to expand at a moderate CAGR during the forecast period.
Anthelmintic drugs are the group of the antiparasite drugs recommended for the
treatment of the helminths in the body. Anthelmintic drugs are used to remove
the parasitic forms, such as roundworm, flatworm, whipworm, and pinworm from
animals and humans. Apart from infecting humans, the helminthic worms widely
impact the livestock, companion animals, and other animals, which is likely to drive
the anthelmintic drugs market.
The global anthelmintic drugs market is driven by rise in prevalence of
human and animal helminthic infections across globe, availability of various
generics medicines, government establishing guidelines for eradication of worm
infections, efforts on increasing awareness about helminthic infections, and
rising incidence of ascariasis across subtropical region, including countries
in Africa and Asia. These factors are likely to propel the anthelmintic drugs
market across the globe. As per the WHO estimation in 2019, around
1.5 to 2 billion people were suffering from soil-transmitted
helminth infections.
Europe dominated the global anthelmintic drugs market in 2019,
followed by Asia Pacific and the trend is anticipated to continue during the
forecast period. The region’s dominance can be ascribed to the presence of key
veterinary as well as human anthelmintic drugs manufacturers, large veterinary
business in the countries in Europe, and high awareness about veterinary animal
health.
Request COVID Analysis on Anthelmintic
Drugs Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=50688
Increase in Prevalence of Helminthic Infections to
Drive Global Market
The growing incidence of helminthic infections among animals and humans
is anticipated to propel the demand for anthelmintic drugs across the globe.
According to the WHO, 1.5 billion people were suffering from
soil-transmitted helminth infections in March 2020, which accounted
for 24% of the world’s population. Hookworm, ascaris, and
whipworm accounted for the largest soil-transmitted helminths burden across the
globe. According to CDC estimates, in 2019, 807 million to 1,221
million people across the world were infected by ascaris, and
around 604 million to 795 million are likely to suffer from
whipworm globally. In the U.S., according to the CDC, pinworm is the most
common helminth infection, with prevalence of 0.2% to 20% in
children.
Globally, 200 million people are affected by enterobius vermicularis
(pinworms), accounting for 30% of the cases globally. Children in the age group
of 5 to 10 years are most susceptible to this infection. Furthermore, as per
the CDC, 2,800 cases of angiostrongylus cantonensis across 30
countries have been reported in 2018. According to a research conducted
in 2019, prevalence of roundworms in dogs ranged from 1.8% to 5.0%,
hookworm infection was estimated to be around 2.5% to 4.5%,
and whipworm infection was reported to be around 0.8% to 1.2%.
Request Customization on Anthelmintic Drugs Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=50688
Anthelmintic Drugs Market: Prominent Regions
In terms of region, the global anthelmintic drugs market has been
segmented into North America, Europe, Asia Pacific, Latin America, and Middle
East & Africa. Europe dominated the global anthelmintic drugs market
in 2019, followed by Asia Pacific. The number of companion animals
in the region is increasing at a higher rate, as compared to that of livestock
animals, due to rise in pet ownership and the presence of key players offering
anthelmintic drugs. This, in turn, is estimated to boost the market in the
region. The anthelmintic drugs market in Asia Pacific is likely to expand at a
highest CAGR from 2020 to 2030. The growth of
the market in the region can be attributed to a large veterinary industry in
China, Australia, and New Zealand; rise in pet care expenditure; increase in
demand for animal care; and surge in veterinary hospitals and clinics in China,
India, South Korea, and Hong Kong. As per research, prevalence of hookworm
infections in the population was estimated to be 19% in July
2018 in countries in Asia Pacific.
Buy Anthelmintic Drugs Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=50688<ype=S
Launching and Approval of Anthelmintic Products by
Key Players to Drive Global Market
The global anthelmintic drugs market is fragmented in terms of the
number of players. The market is dominated by key players with strong
geographic presence. Key players operating in the global anthelmintic drugs
market includes Novartis AG, Zoetis, Inc., Amneal Pharmaceuticals Inc.,
Cipla Inc., Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Sun Pharmaceutical
Industries Ltd, GlaxoSmithKline plc, Bayer AG, Merck & Co. Inc.(Intervet
Inc.), and Boehringer Ingelheim International GmbH. In February
2020, Zoetis, Inc. received approval for Simparica Trio drug, a
combination used as a prevention for heartworm disease, roundworms, ricks,
hookworms, and fleas in dogs. In February 2019, Novartis AG
received FDA approval for Egaten drug for the treatment of the fascioliasis,
also known as liver fluke infestation, in patients with age of 6 years or
older.
Global Anthelmintic Drugs Market: Segmentation
·
o
o
o
·
o
o
·
o
§
§
o
·
o
o
o
o
o
·
o
o
o
o
o
·
o
§
§
o
§
§
§
§
§
§
o
§
§
§
§
§
o
§
§
§
o
§
§
§
About Us
Transparency Market Research is a global market intelligence company
providing global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides forward-looking
insight for several decision makers. Our experienced team of analysts,
researchers, and consultants uses proprietary data sources and various tools
and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of
research experts so that it always reflects latest trends and information. With
a broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
